Cargando…
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab
Interpretation of changes in the T1- and T2-weighted MR images from patients with newly diagnosed glioblastoma (GBM) treated with standard of care in conjunction with anti-angiogenic agents is complicated by pseudoprogression and pseudoresponse. The hypothesis being tested in this study was that 3D...
Autores principales: | Nelson, Sarah J., Li, Yan, Lupo, Janine M., Olson, Marram, Crane, Jason C., Molinaro, Annette, Roy, Ritu, Clarke, Jennifer, Butowski, Nicholas, Prados, Michael, Cha, Soonmee, Chang, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069332/ https://www.ncbi.nlm.nih.gov/pubmed/27535746 http://dx.doi.org/10.1007/s11060-016-2229-3 |
Ejemplares similares
-
Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor()()
por: Autry, Adam, et al.
Publicado: (2017) -
Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials()
por: Wen, Qiuting, et al.
Publicado: (2015) -
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
por: Wen, Qiuting, et al.
Publicado: (2014) -
Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
por: Li, Yi, et al.
Publicado: (2017) -
Magnetic resonance analysis of malignant transformation in recurrent glioma
por: Jalbert, Llewellyn E., et al.
Publicado: (2016)